Chemical industry hasn’t yet developed an appetite for biocatalysis, survey finds

Most industrial labs, especially in the pharmaceutical sector, are not routinely using biocatalysis. That is the top take-home message from a survey of senior leaders at fine chemicals companies. It identified a lack of appropriate education at university level and a lack of available infrastructure as the main barriers to companies using biocatalysis and chemoenzymatic catalysis.Misconceptions along with a lack of time and resources driving industry’s reluctant attitude to biocatalysis and chemoenzymatic catalysis.